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Abstract
Background—A 24-year-old man presented with previously diagnosed Marfan’s syndrome. Since
the age of 9 years, he had undergone eight cardiovascular procedures to treat rapidly progressive
aneurysms, dissection and tortuous vascular disease involving the aortic root and arch, the
thoracoabdominal aorta, and brachiocephalic, vertebral, internal thoracic and superior mesenteric
arteries. Throughout this extensive series of cardiovascular surgical repairs, he recovered without
stroke, paraplegia or renal impairment.
Investigations—CT scans, arteriogram, genetic mutation screening of transforming growth factor
β receptors 1 and 2.
Diagnosis—Diffuse and rapidly progressing vascular disease in a patient who met the diagnostic
criteria for Marfan’s syndrome, but was later rediagnosed with Loeys–Dietz syndrome. Genetic
testing also revealed a de novo mutation in transforming growth factor β receptor 2.
Management—Regular cardiovascular surveillance for aneurysms and dissections, and aggressive
surgical treatment of vascular disease.
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Learning objectives
Upon completion of this activity, participants should be able to:
1. List characteristics of Marfan’s syndrome.
2. List characteristics of Loeys–Dietz syndrome.
3. Identify genetic mutations associated with Marfan’s syndrome and Loeys–Dietz
syndrome.
4. Describe essential elements of management of Loeys–Dietz syndrome.
THE CASE
A 24-year-old man presented with rapidly progressive aneurysms, dissection and tortuous
vascular disease involving the aortic root and arch, thoracoabdominal aorta, and the
brachiocephalic, vertebral, internal thoracic and superior mesenteric arteries. At 7 years of age,
the patient had been diagnosed with Marfan’s syndrome (MFS) following surgical repair of
pectus excavatum. During a subsequent clinical assessment, the patient was noted to have an
aortic root diameter of 4.0 cm. At the age of 9 years the patient underwent aortic root
replacement with a composite valve graft because his aortic root diameter had expanded to 5
cm with associated aortic valve insufficiency and chest pain.
The patient remained clinically well until the age of 17 years, when he presented with an acute
dissection involving the entire remaining aorta. He underwent graft replacement of the distal
ascending aorta and transverse aortic arch using the elephant trunk technique, with re
attachment of the brachiocephalic arteries as a patch. Within 3 months of the initial dissection
and repair, the patient’s thoracoabdominal aorta had expanded to a diameter of 5 cm. His entire
thoracoabdominal aorta was replaced with a graft from the level of the left subclavian artery
to the aortoiliac bifurcation (a Crawford extent II repair) with reattachment of the T11 and L1
segmental arteries, celiac axis, superior mesenteric artery and both renal arteries (Figure 1).
He subsequently required surgical repair of symptomatic and rapidly expanding aneurysms in
the left internal carotid artery after 2 months and in the superior mesenteric artery after 3
months. When he was 19 years old, the patient underwent surgical repair of aneurysms in the
innominate, bilateral subclavian, right vertebral, bilateral common carotid and left internal
thoracic arteries; the latter measured 3.6 cm in diameter (Figure 2A–C). He presented with a
right internal thoracic artery aneurysm 3.5 years later, which was treated by direct percutaneous
injection of fibrin glue.
At the age of 24 years, the patient returned to the hospital with a pseudoaneurysm involving
the right subclavian artery, and marked tortuosity of the adjacent supraclavicular branch vessels
was noted (Figure 3). His aneurysm was treated by percutaneous endovascular obliteration
using a combination of platinum coils and hydrocoils. He recovered from the extensive
cardiovascular procedures without stroke, paraplegia or renal impairment. Surgical repairs
were not complicated by excessively friable tissues or bleeding. The patient has been closely
monitored with serial imaging studies of his chest, abdomen and cerebral vasculature. Physical
examination at the age of 24 years revealed a thin young man with mildly dysmorphic features
with hypertelorism, micrognathia, malar flattening, downslanting palpebral fissures, a long
philtrum with a thin upper lip, a highly arched palate and bifid uvula (Figure 4). Skeletal
features of MFS included a repaired pectus excavatum, scoliosis, pes planus and joint laxity.
Ophthalmologic examination was notable for absence of ectopia lentis. His skin was velvety
to the touch and translucent with visible veins. The patient had a history of inguinal hernias,
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with repairs performed at the age of 3 and 6 weeks, 6 months and 6 years. Imaging studies
showed that he had elongated lung fields (Figure 5A,B) and lumbosacral dural ectasia. Features
of MFS were absent in the patient’s parents and sister.
The patient presented with features of both MFS and Loeys–Dietz syndrome (LDS), prompting
us to carry out DNA sequencing of the genes transforming growth factor β (TGF-β) receptors
1 and 2 (TGFBR1 and TGFBR2). Mutation screening of TGFBR2 revealed a heterozygous
missense mutation (C1582>T), resulting in substitution of a cysteine for an arginine at amino
acid 528 (Arg528Cys). This mutation has been previously identified in an unrelated patient
with LDS.1 Sequencing of DNA obtained from the patient’s parents and unaffected sister did
not reveal the TGFBR2 mutation, indicating that the mutation occurred de novo in the patient
and that no additional family members were at risk for the disease.
DISCUSSION OF DIAGNOSIS
MFS is an autosomal dominant genetic disorder, and classical features include cardiovascular
defects (ascending aortic aneurysms, aortic dissections and mitral valve abnormalities),
skeletal manifestations (pectus deformities, scoliosis, dolichostenomelia, arachnodactyly, joint
laxity and a highly arched palate) and ocular complications (ectopia lentis, retinal detachment
and myopia).2 Diagnostic criteria for MFS—currently known as the Ghent criteria—
emphasize the aortic aneurysms and dissections, a constellation of skeletal findings, ectopia
lentis, dural ectasia and the affected patient’s family history.3 Since the patient presented here
had aortic aneurysm and dissection, skeletal features and dural ectasia, he met the Ghent
diagnostic criteria for MFS.
In the early 1990s, causative mutations for MFS were identified in the gene encoding the
extracellular matrix protein fibrillin 1 (FBN1), and initially there was no evidence of genetic
heterogeneity.4,5 In 1994, MFS was described in a large French kindred, in which the
phenotype could not be linked to markers in close proximity to FBN1, providing the first
evidence that MFS is genetically heterogeneous.6 The disease-causing locus in this family was
mapped to chromosome 3p24–25 and the diagnosis of MFS, as well as the validity of the
linkage analysis, was debated in the literature.7 Subsequent studies, however, confirmed that
the 3p locus was associated with aortic disease through linkage mapping in a family with
thoracic aortic aneurysms and dissections (TAAD), and mapped the causative gene to the same
chromosomal locus.8 In the French kindred, the defective gene at the 3p24–25 locus associated
with disease was identified as TGFBR2.9 Mutations in TGFBR2 were subsequently identified
in three additional, unrelated, MFS families and have also been identified in four unrelated
families with familial TAAD who did not meet the diagnostic criteria for MFS.9,10 In these
families with TAAD and TGFBR2 mutations, the primary vascular disease was progressive
enlargement of the ascending aorta leading to dissection. Affected individuals also developed
aneurysms and dissections involving the descending thoracic aorta and other arteries.10
Heterozygous mutations in either TGFBR1 or TGFBR2, including de novo mutations, have
also been associated with LDS—a disorder that was initially described by Furlong and
delineated more completely by Loeys and colleagues.1,11,12 Clinical features of LDS include
vascular disease, craniosynostosis, cleft palate/bifid uvula, hypertelorism, congenital heart
defects (patent ductus arteriosus and atrial septal defect) and mental retardation. Patients with
LDS present with aneurysms or dissections of the ascending aorta, similar to those observed
in patients with MFS. In LDS, however, these defects are more likely to manifest at a young
age, and death from aortic disease can occur when patients are as young as 3 years. In contrast
to MFS, generalized arterial tortuosity and aneurysms of other arteries have been noted in
patients with LDS. Mutations in TGFBR2 are, therefore, associated with a spectrum of aortic
disease syndromes, including LDS, MFS and familial TAAD, and the age of onset of aortic
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disease can range from 3–82 years.1,10 Interestingly, mutations in TGFBR1 or TGFBR2 have
not been reported in patients with ectopia lentis, a clinical feature that seems to be specific for
MFS owing to mutations in FBN1. Although the patient described here met the Ghent
diagnostic criteria for MFS, LDS was considered a more accurate diagnosis because he also
had features of LDS, such as bifid uvula, hypertelorism and arterial tortuosity. Current reports
indicate that TGFBR1 and TGFBR2 mutations are rare in patients who meet the Ghent
diagnostic criteria, but the present case indicates that the diagnostic criteria for MFS need to
be revised and those for LDS established, so that the correct diagnosis can be made and vascular
disease managed properly.9,13,14
FBN1 mutational analysis is not routinely recommended for diagnosis of MFS because of the
complexity of the gene and identification of FBN1 mutations causing related phenotypes.15
We would recommend TGFBR1/2 mutational analysis in patients with features of LDS and
familial TAAD. In addition, the literature and our current clinical experience suggest that
TGFBR1/2 mutational analysis should be considered in patients with MFS who do not have
ectopia lentis. Recommendations for genetic testing of individuals with TAAD need to be
addressed as part of the revised diagnostic criteria for these disorders.
TREATMENT AND MANAGEMENT
As this case illustrates, arterial disease associated with TGFBR2 mutations is diffuse and
progresses more rapidly than in classic MFS resulting from FBN1 mutations where the vascular
disease is mainly limited to the aorta.16 Although the optimal treatment strategy for patients
with aortic aneurysm syndromes associated with TGFBR2 mutations has not yet been
delineated, initial data indicate that vascular disease should be aggressively managed, whether
the associated diagnosis is LDS, MFS or familial TAAD. A noteworthy case is that of an adult
patient with a TGFBR2 mutation who presented at our institution with acute aortic dissection
a few months after a maximal aortic dimension of only 4.2 cm had been documented (DM
Milewicz, unpublished data). To prevent life-threatening rupture or dissection, we recommend,
therefore, that patients with TGFBR2 mutations undergo cardiovascular surveillance for
aneurysms and dissection using imaging modalities such as CT scans and magnetic resonance
angiography, followed by aggressive surgical treatment of identified vascular disease.
CONCLUSION
Compared with FBN1 mutations causing classic MFS, TGFBR2 mutations are associated with
more extensive and progressive aortic and peripheral vascular disease. Furthermore, patients
with TGFBR2 mutations might have features usually absent in classic cases of MFS, including
hypertelorism, bifid uvula and marked arterial tortuosity. We recommend that patients with
TGFBR2 mutations receive diligent lifelong cardiovascular surveillance and aggressive
surgical management, whether the diagnosis is LDS, MFS or familial TAAD.
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Illustration showing the results of three aortic operations the patient underwent between the
ages of 9 and 18 years, involving graft replacement of the aortic root, ascending aorta,
transverse aortic arch and entire thoracoabdominal aorta.
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Imaging and reconstruction of aneurysms in arteries originating from the aortic arch. (A) A
drawing and (B) preoperative CT scan showing aneurysms identified in the patient at the age
of 19 years. (C) Illustration showing graft repair of the superior transverse aortic arch with
graft replacement of the brachiocephalic vessels and ligation of the left internal thoracic artery
through an upper hemisternotomy. Abbreviations: IA, innominate artery; ITA, internal thoracic
arteries; SCA, subclavian artery.
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Arteriogram demonstrating marked tortuosity of the supraclavicular branch vessels
(arrowhead) and a pseudoaneurysm involving the right subclavian artery (arrow).
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Photographs illustrating the patient’s mildly dysmorphic facial features, including
hypertelorism, micrognathia, downslanting palpebral fissures and long philtrum with a thin
upper lip, and skeletal features, including a repaired pectus excavatum, scoliosis and pes planus.
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Radiographs demonstrating elongated lung fields of the chest. (A) Posteroanterior and (B)
lateral chest radiographs demonstrating elongated lung fields. The radiodense material in the
right upper peristernal region (indicated by arrows) is fibrin glue within the thrombosed right
internal thoracic artery aneurysm.
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